I absolutely love technical analysis but this needs a reality check.
Kanewmann
⋅
@speedoh, wtf you are commenting negative, on every MRNA analyst LOL.
Are you a shorter?
speedoh
⋅
@Kanewmann, Just trying to help out. Vaccine revenues are completely baked in. There's a reason why MRNA dropped after FDA approval. Who in their right mind would buy now? I do think this will get to 200+....in a year. I will load up again when it falls under 100. This thing hits >150 again and there will be profit taking. There's no demand for an overbought stock like this to get to 200 for a while.
GaryBeta
⋅
My reality check check says likely right. I have a 100% upside target 90 days! FDA tonight has voted 20-0-1 to approve EUA. And the mRNA process is equipped to stop many other diseases as well.
speedoh
⋅
@GaryBeta, I hope you're right, but I think this is a very long play to get there... Everything else in Moderna pipeline is several years away from market. I'm not sure what else would drive this up in the short term, the next 12 months of vaccine revenue already baked into current price.
andplaia
⋅
@speedoh, not only mRNA, theres siRNA and RNAi treatment for potentially every disease like cancer or even genetic like cysctic fibrosis or huntingtons. hope in a couple of years this company brings this biotech to life
speedoh
⋅
@andplaia, It will! and I am going toload up when this falls below 100 knowing it's a $600 stock in a couple years! But it will take time, all their other vaccine candidates will go through traditional clinical testing protocols so they have nothing viable in market beyond covid for 2-4 years.